Urine and serum proteomic-based biomarkers, like SPARC24, SH3 domain binding glutamic acid-rich protein like 3 (SH3BGRL3)25 have been recently reported as prognostic markers for BC. This evidence concerns the gene SH3BGRL3 and breast cancer.